The implantation of cardiac devices significantly reduces morbidity and mortality in patients
with cardiac arrhythmias. Arrhythmias as well as therapy delivered by the device may impact …

Objectives Communication about deactivation of implantable cardioverter-defibrillator (ICD)
therapy at end-of-life (EoL) is a recognised issue within clinical practice. The aim of this …

Background Inflammation has been associated with progression and complications of
chronic heart failure (HF) but no effective therapy has yet been identified to treat this …

Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at
high risk of developing major adverse cardiovascular events (MACE). This is a multicenter …

Background: The gold standard for the treatment of cardiac implantable electronic devices
(CIEDs)-related infection and lead malfunction is transvenous lead extraction (TLE). To date …

Implantable cardioverter defibrillators (ICDs) significantly contribute to the prevention of
sudden cardiac death in selected patients. However, it is essential to identify those who are …

Objective: Little is known about the fate of bypass grafts to the right coronary system. To
investigate the long-term patency of venous bypass grafts directed to the right coronary …

Background: This study aimed to investigate the effects of a home-based exercise training
program on Cardiac Autonomic Neuropathy (CAN) and metabolic profile in Diabetic Kidney …

Aims We aimed to establish sex-specific predictors for 1-year VT recurrence and 1-year all-
cause mortality in patients with structural heart disease undergoing catheter ablation …

Introduction: Biventricular pacing has been the gold standard for cardiac resynchronization
therapy in patients with left bundle branch block and severely reduced left ventricular …